Protein kinase C (PKC)-mediated phosphorylation of α-tubulin
at Ser165 or expression of phosphomimetic (S165D)-α-tubulin
stimulates microtubule (MT) polymerization (Cytoskeleton
2014, 71, 257–272). Ser165
lies near the interface between adjacent αβ-tubulin heterodimers
and helix H8, which contains Glu254, the catalytic residue in α-tubulin
that hydrolyzes the exchangeable GTP in β-tubulin (β:GTP)
and triggers MT depolymerization. It was hypothesized that S165D,
a phosphomimetic variant of α-tubulin, perturbs the alignment
of α:Glu254 with respect to β:GTP, thereby impairing its
hydrolysis. Molecular simulations were performed with cryoEM structures
of MTs (PDB ID: 3J6E) in which phosphomimetic S165D or control S165N had been substituted.
Unlike native and S165N structures, the distance between S165D and
α:Glu254 increased by 0.6 Å, while the distance between
α:Glu254 and β:GTP decreased by 0.4 Å. Rotation of
β:GTP by 4 Å occurred in the S165D variant, whereas β:GTP
in the S165N control was unchanged from the native structure. Additionally,
the S165D variant exhibited an altered pattern of H-bonding to β:GTP,
including the loss of three H-bonds. The significance of these findings
to β:GTP hydrolysis was analyzed in MCF-10A human breast cells
treated with an antibody that detects GTP-bound tubulin. Compared
with controls, GTP–tubulin signals were at higher levels in
cells that ectopically expressed S165D-α-tubulin (TUBA1C) or
had been treated with PKC activator DAG-lactone to induce phosphorylation
of Ser165 in native α-tubulin. These findings support a model
whereby conformational changes induced by Ser165 phosphorylation alter
the spatial relationship between β:GTP and α:Glu254, thereby
slowing GTP hydrolysis and promoting GTP caps.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.